Literature DB >> 21261719

Healthy range for serum ALT and the clinical significance of "unhealthy" normal ALT levels in the Korean population.

Hyun Seok Kang1, Soon Ho Um, Yeon Seok Seo, Hyonggin An, Kwang Gyun Lee, Jong Jin Hyun, Eun Sun Kim, Sung Chul Park, Bora Keum, Ji Hoon Kim, Hyung Joon Yim, Yoon Tae Jeen, Hong Sik Lee, Hoon Jai Chun, Chang Duck Kim, Ho Sang Ryu.   

Abstract

BACKGROUND AND AIMS: It remains unclear whether the currently-used normal range for serum alanine aminotransferase (ALT) levels really reflects a healthy liver. The present study was conducted to evaluate the healthy range of serum ALT in the Korean adult population and to determine the clinical significance of unhealthy levels.
METHODS: We reviewed the medical records, including questionnaires and the results of laboratory and radiological tests conducted at the Health Promotion Center at Korea University Anam Hospital between March 2005 and February 2007. The records, written in questionnaire form, included baseline data, such as physical status, social behaviors, medication history, and past and present disease histories.
RESULTS: The mean age of the 7403 enrolled patients was 48 years, and 49.9% of these patients were male. A healthy cohort was selected after excluding patients who showed any abnormalities of the factors that were significantly associated with the serum ALT level upon multivariate regression analysis. The upper limit of the healthy range of the serum ALT level (i.e. 95th percentile) in the healthy population was 31 IU/L for males and 23 IU/L for females. The prevalence of metabolic syndrome and insulin resistance (IR) were significantly higher in patients with an 'unhealthy' normal ALT level than in those with a healthy ALT level.
CONCLUSION: In our study, the upper limit of the healthy range of the serum ALT level was 31 IU/L for males and 23 IU/L for females. An unhealthy normal ALT level was associated with a higher prevalence of metabolic syndrome and IR.
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21261719     DOI: 10.1111/j.1440-1746.2010.06481.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  22 in total

1.  Low Alanine Aminotransferase Levels in the Elderly Population: Frailty, Disability, Sarcopenia, and Reduced Survival.

Authors:  Umberto Vespasiani-Gentilucci; Antonio De Vincentis; Luigi Ferrucci; Stefania Bandinelli; Raffaele Antonelli Incalzi; Antonio Picardi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2018-06-14       Impact factor: 6.053

Review 2.  KASL clinical practice guidelines for management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2019-06-12

3.  Upper limits of normal for alanine aminotransferase activity in the United States population.

Authors:  Constance E Ruhl; James E Everhart
Journal:  Hepatology       Date:  2012-02       Impact factor: 17.425

4.  Rapid Alanine Aminotransferase Normalization with Entecavir and Hepatocellular Carcinoma in Hepatitis B Virus-Associated Cirrhosis.

Authors:  Eui Joo Kim; Jong Eun Yeon; Oh Sang Kwon; Heon Nam Lee; Seung Kak Shin; Seong Hee Kang; Kwan Soo Byun; Jeong Han Kim; So Young Kwon; Sang Jun Suh; Hyung Joon Yim; Yun Soo Kim; Ju Hyun Kim
Journal:  Dig Dis Sci       Date:  2016-12-29       Impact factor: 3.199

5.  Disease progression in chronic hepatitis C patients with normal alanine aminotransferase levels.

Authors:  Dong Hyun Sinn; Geum-Youn Gwak; Jae-Uk Shin; Moon Seok Choi; Joon Hyeok Lee; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

6.  Pooled genetic analysis in ultrasound measured non-alcoholic fatty liver disease in Indian subjects: A pilot study.

Authors:  Vishnubhotla Venkata Ravi Kanth; Mitnala Sasikala; Padaki Nagaraja Rao; Urmila Steffie Avanthi; Kalashikam Rajender Rao; Duvvuru Nageshwar Reddy
Journal:  World J Hepatol       Date:  2014-06-27

7.  Upper Normal Alanine Aminotransferase Range and Insulin Resistance in Korean Adolescents: Korean National Health and Nutrition Examination Survey, 2009-2010.

Authors:  Yoon Lee; Kyung-Do Han; Jennifer Jaeeun Jung; Kee-Hyoung Lee; Kyung-Hwan Cho; Yang-Hyun Kim
Journal:  Dig Dis Sci       Date:  2015-12-24       Impact factor: 3.199

8.  Elevated alanine aminotransferase activity is not associated with dyslipidemias, but related to insulin resistance and higher disease grades in non-diabetic non-alcoholic fatty liver disease.

Authors:  Mohammad Ebrahim Ghamar-Chehreh; Mohsen Amini; Hossein Khedmat; Seyed Moayed Alavian; Fatemeh Daraei; Reza Mohtashami; Reza Hadi; Bent-Al-Hoda Beyram; Saeed Taheri
Journal:  Asian Pac J Trop Biomed       Date:  2012-09

9.  Can "healthy" normal alanine aminotransferase levels identify the metabolically obese phenotype? Findings from the Korea national health and nutrition examination survey 2008-2010.

Authors:  Hee Yeon Kim; Chang Wook Kim; Chang Don Lee; Jong Young Choi; Chung-Hwa Park; Si Hyun Bae; Seung Kew Yoon; Kyungdo Han; Yong-Moon Park
Journal:  Dig Dis Sci       Date:  2014-04-06       Impact factor: 3.199

10.  Whole-Exome Sequencing Identifies a Variant in Phosphatidylethanolamine N-Methyltransferase Gene to be Associated With Lean-Nonalcoholic Fatty Liver Disease.

Authors:  Govardhan Bale; Ravikanth V Vishnubhotla; Sasikala Mitnala; Mithun Sharma; Rao N Padaki; Smita C Pawar; Reddy N Duvvur
Journal:  J Clin Exp Hepatol       Date:  2019-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.